John Bencich - 02 Apr 2026 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: AEON
Reported as of: 02 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2026, 18:22:30 UTC
Prior SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Alexander Wilson, as Attorney-in-Fact, for John Bencich

Key filing fact

John Bencich filed Form 4 for AEON Biopharma, Inc. (AEON) on 03 Apr 2026.

Key facts

This page summarizes John Bencich's Form 4 filing for AEON Biopharma, Inc. (AEON).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Apr 2026, 18:22.

Change

Previous filing in this sequence was filed on 03 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001477056 Primary reporting owner

Bencich John

Relationship: CHIEF FINANCIAL OFFICER
Address: C/O AEON BIOPHARMA, INC., 5 PARK PLAZA, SUITE 1750, IRVINE
Signature: /s/ Alexander Wilson, as Attorney-in-Fact, for John Bencich
Signature date: 03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AEON transaction

Class A Common Stock

Award

Transaction value
Shares: +754,717
Change %
Price: $0.000000^*
Shares after: 754,717
Date: 02 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units granted on April 1, 2026 (the "Grant Date"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date.